Janssen Scientific Affairs

Janssen Scientific Affairs, LLC is the medical affairs and scientific communications arm of Johnson & Johnson Innovative Medicine, the pharmaceutical division of Johnson & Johnson. Based in Titusville, New Jersey, the company is responsible for bridging the gap between clinical development and real-world clinical practice by providing evidence-based medical information and health economics research. It supports a vast portfolio of therapies across oncology, immunology, neuroscience, and cardiovascular disease, including blockbuster products like Stelara, Darzalex, and Tremfya. The organization plays a critical role in demonstrating the clinical and economic value of J&J's innovative medicines to healthcare providers, payers, and patients. Through Phase 4 studies and real-world evidence generation, Janssen Scientific Affairs ensures the safe and effective use of the company's life-changing treatments.